Annette Schavan, the German minister for education and research, has had her PhD revoked by the University of Dusseldorf following an investigation into alleged plagiarism.
Der Spiegel reports: Continue reading German education and research minister Schavan loses doctorate over plagiarism
There’s a new retraction in the journal Carbon.
The case didn’t involve a Carbon copy — say, plagiarism or duplication — but rather an instance of fraud in a Japanese university, part of a larger case we covered last August.
Here’s the retraction notice for the paper, “The role of Fe species in the pyrolysis of Fe phthalocyanine and phenolic resin for preparation of carbon-based cathode catalysts,” which appeared in August 2010: Continue reading “False data” forces retraction of Carbon paper co-authored by postdoc who led to PI’s suspension
If you went looking for ten of our posts about Anil Potti today, you would have seen error messages instead. That’s because someone claiming to be from a news site in India alleged we violated their copyright with those ten posts about the former Duke University cancer researcher who has had 19 papers retracted, corrected, or partially retracted.
The truth of the matter, as is often the case, is exactly the opposite of the allegations. Here’s the email we received from Automattic — which owns WordPress, our blog host — earlier today: Continue reading WordPress removes Anil Potti posts from Retraction Watch in error after false DMCA copyright claim
Diederik Stapel has a new retraction, his 46th.
Here’s the notice for “The effects of diffuse and distinct affect. ” by Diederik A. Stapel, Willem Koomen and Kirsten I. Ruys, which appeared in the Journal of Personality and Social Psychology in 2002: Continue reading Retraction 46 arrives for Diederik Stapel
The FASEB Journal has retracted a 2012 paper by a group from the University of Alabama, Birmingham (UAB), looking at the role of a tumor-suppressing micro-RNA in pulmonary fibrosis. The retraction suggests the provenance of the data are in question, and we learned details of what went wrong.
Here’s the notice, which, sadly, is behind a $12-per-day paywall: Continue reading Author retracts FASEB Journal paper for data reuse
A paper that shares a first author with a paper retracted in December has been corrected.
Late last year, we reported on a retraction in Antioxidants & Redox Signaling (ARDS) by Indika Edirisinghe, who was at the University of Rochester when the original paper was published, and colleagues. On January 17, the Journal of Agricultural and Food Chemistry published a correction to “Effect of Black Currant Anthocyanins on the Activation of Endothelial Nitric Oxide Synthase (eNOS) in Vitro in Human Endothelial Cells,” on which Edirisinghe is also first author.
His affiliation on that paper, originally published in July 2011, is the Illinois Institute of Technology. Here’s the correction: Continue reading First author of recently retracted paper has another corrected, in J Ag Food Chem
Hiroaki Matsubara, a prominent cardiologist with five Expressions of Concern and two retractions for his CV, has another retraction.
As Larry Husten, who first reported the retraction at Forbes, notes, the notice for 2009’s “Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study,” which appeared in the European Heart Journal, says very little: Continue reading Study of blood pressure drug valsartan retracted
The U.S. Office of Research Integrity has sanctioned Bryan William Doreian, a former postdoc in dermatology at Case Western Reserve University in Cleveland, for falsifying data in his dissertation and a 2009 paper in Molecular Biology of the Cell (for which it provided a cover image, at right).
ORI says Doreian’s bad NIH-funded data also appeared in a manuscript submitted to, but never published in, Nature Medicine.
Here are the papers cited in the finding: Continue reading ORI says Case Western skin scientist falsified data
A group of neonatologists in Germany has retracted a paper after apparently realizing that their data weren’t what they thought they were.
Here’s the notice, for “Low Dose Lidocaine for Refractory Seizures in Preterm Neonates,” which appeared in the Indian Journal of Pediatrics: Continue reading Seizure study retracted after authors realize data got “terribly mixed”
Here’s a nice example of how science should work.
A team of Swiss microbiologists has retracted their 2012 paper in PLoS One on the genetics of the TB mycobacterium after learning that the fusion protein they thought they’d used in their study was in fact a different molecule.
Here’s the retraction notice for the article, “A β-lactamase based reporter system for ESX dependent protein translocation in mycobacteria,” which has been cited once, according to Thomson Scientific’s Web of Knowledge: Continue reading “Unreliable” findings fell TB gene study in PLOS ONE